Boothbay Fund Management’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Boothbay Fund Management’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,069	Closed	-$60.4K	–	2178
2023 Q2	$60.4K	Hold	2,069	–	–	﹤0.01%	1665
2023 Q1	$47.7K	Hold	2,069	–	–	﹤0.01%	2026
2022 Q4	$29.8K	Hold	2,069	–	–	﹤0.01%	1906
2022 Q3	$50K	Sell	2,069 -218	-10%	-$5.62K	﹤0.01%	2117
2022 Q2	$45K	Hold	2,287	–	–	﹤0.01%	2084
2022 Q1	$82K	Hold	2,287	–	–	﹤0.01%	2129
2021 Q4	$102K	Sell	2,287 -2,410	-51%	-$144K	﹤0.01%	1717
2021 Q3	$334K	Buy	4,697 +1,424	+44%	+$162K	0.01%	1274
2021 Q2	$432K	Hold	3,273	–	–	0.01%	1084
2021 Q1	$439K	Sell	3,273 -2,014	-38%	-$255K	0.02%	1007
2020 Q4	$387K	Buy	+5,287	New	+$388K	0.01%	851

Other funds holding ASLN

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Boothbay Fund Management's ASLN Position: Q3 2023 in Review

Boothbay Fund Management sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2023, closing a stake of 2,069 shares — an estimated $60.4K sold.

Boothbay Fund Management first reported a position in ASLN in Q4 2020 and held it in 11 quarters. The position peaked at $439K in Q1 2021. 19 funds tracked by Wall St. Rank hold ASLN as of Q3 2023.

Boothbay Fund Management reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2023 after selling out during the quarter.
Boothbay Fund Management sold 2,069 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2023, an estimated $60.4K.
Boothbay Fund Management first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q4 2020 and held it in 11 quarters.
Boothbay Fund Management's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $439K in Q1 2021.
19 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2023.

Based on Boothbay Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.